Evidence map›Paper›PMID 36016561›Full record

ArticleFrontiers in pharmacology2022

Therapeutic mechanism of

Chenghao Fei, De Ji, Huangjin Tong, Yu Li, Lianlin Su, Yuwen Qin, Zhenhua Bian, Wei Zhang, Chunqin Mao, Lin Li and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Ethanol extract ofFrontiers in pharmacology · 2025
    Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Chenghao FeiSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
De JiSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
Huangjin TongDepartment of Pharmacy, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
Yu LiSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
Lianlin SuSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
Yuwen QinSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
Zhenhua BianSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
Wei ZhangSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
Chunqin MaoSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
Lin LiSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
Tulin LuSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
Nanjing University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

coronary heart diseaseCurcuma aromatica Salisb. rhizomelipidomicsnetwork pharmacologypharmacodynamic substancestherapeutic mechanism

Identifiers

PMID36016561
PMCPMC9396035
OpenAlexW4291720572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.